SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Progenics Pharmaceuticals Inc. (PGNX)

PGNX RSS Feed
Add PGNX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/11/2017 1:24:56 PM - Followers: 59 - Board type: Free - Posts Today: 0

http://www.progenics.com/

http://finance.yahoo.com/q/ks?s=PGNX

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for the treatment of unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States. It primarily focuses on the areas of gastroenterology, virology, and oncology. The company's development programs and product candidates include methylnaltrexone-subcutaneous, which completed Phase 3 clinical trial for the treatment of opioid-induced constipation; methylnaltrexone-intravenous, which is under Phase 3 clinical trial for the management of post-operative ileus; and Methylnaltrexone-Oral, a Phase 2 clinical trial oral form for the treatment of opioid-induced constipation. It is also developing PRO 140 Phase 1b clinical trial, designed to block HIV infection by inhibiting virus-cell binding; ProVax, a vaccine product candidate for the prevention of HIV infection or therapeutic treatment for HIV-positive individuals; and GMK Vaccine, a therapeutic vaccine, which is in Phase 3 clinical trial for the prevention of recurrence of melanoma. In addition, the company engages in a research program to discover treatments for hepatitis C, a chronic liver disease that block viral entry into cells. Further, Progenics Pharmaceuticals, through a joint venture with Cytogen Corporation, is developing in vivo immuno-therapies for treatment of prostate cancer, including a human monoclonal antibody-drug conjugate directed against prostate-specific membrane antigen (PSMA). The company's PSMA vaccine is in Phase 1 clinical testing. It has a collaboration agreement with Wyeth Pharmaceuticals to develop and commercialize subcutaneous, intravenous, and oral forms of methylnaltrexone. The company was incorporated in 1986 and is based in Tarrytown, New York.





 

PGNX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PGNX News: Current Report Filing (8-k) 07/18/2017 04:51:16 PM
PGNX News: Statement of Changes in Beneficial Ownership (4) 06/15/2017 04:43:06 PM
PGNX News: Current Report Filing (8-k) 06/15/2017 04:14:58 PM
PGNX News: Statement of Changes in Beneficial Ownership (4) 06/15/2017 03:10:40 PM
PGNX News: Statement of Changes in Beneficial Ownership (4) 06/15/2017 03:10:40 PM
PostSubject
#670   News is needed with PGNX oxnous 07/11/17 01:24:56 PM
#669   What a rough couple of weeks for PGNX vinmantoo 05/05/17 12:15:58 AM
#668   Just bought another 600 shares at 8.35 DorseyE 05/02/17 08:32:06 AM
#667   Just bought another 600 shares at 8.35 DorseyE 05/02/17 08:32:06 AM
#666   Just bought 2k @8.00.... DorseyE 05/01/17 08:47:40 AM
#665   Short Interest as of 4/13/2017...... 7,977,161 according to DorseyE 04/25/17 08:02:41 PM
#664   Progenics Moves Ahead Towards NDA Filing For Azedra DorseyE 04/22/17 12:49:52 AM
#663   Progenics (NASDAQ:PGNX) has declined about 7% despite meeting DorseyE 04/07/17 02:35:31 PM
#662   The markets are talking, anyone know what it's saying? DorseyE 04/05/17 04:14:00 PM
#661   WOW, never expected this! DorseyE 04/04/17 01:29:30 PM
#660   Short Interest as of 3/15/2017..... I wonder what DorseyE 03/30/17 07:14:12 PM
#659   Bought 1500 shares at 9.21 today! DorseyE 03/30/17 05:21:41 PM
#658   Short Interest DorseyE 03/09/17 08:39:36 PM
#657   I sold some PGNX yesterday & today! DorseyE 03/02/17 04:22:23 PM
#656   Great move today, actually looking for more upgrades DorseyE 02/28/17 12:44:49 AM
#655   Check this out DorseyE 02/22/17 05:42:02 PM
#654   Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing Dr_Thorfin 02/14/17 09:48:34 AM
#653   Excellent news for PGNX as the phase 3 vinmantoo 12/23/16 03:04:08 PM
#652   I am hoping we see a confirmation of Betchips 11/13/16 02:44:31 PM
#651   Looks like if this crosses $7 it's going vinmantoo 11/12/16 05:25:04 PM
#650   * * $PGNX Video Chart 11-09-16 * * ClayTrader 11/09/16 04:35:20 PM
#649   Looks like if this crosses $7 it's going Betchips 11/09/16 12:05:03 PM
#648   * * $PGNX Video Chart 11-08-16 * * ClayTrader 11/08/16 05:20:16 PM
#647   Valeant in Talks to sell Salix Unit to Bickema 11/01/16 04:05:56 PM
#646   10 weeks left in 2016 And still 5 major Dr_Thorfin 10/19/16 10:38:27 AM
#645   70mil outstanding shares Institutional Ownership 84.34% Insiders ownership 2,6% Dr_Thorfin 10/17/16 06:20:51 PM
#644   Nice to see PGNX FINALLY start getting close vinmantoo 10/04/16 12:18:43 PM
#643   Progenics Pharma (PGNX): Profitability Could Come In '17 Bickema 10/04/16 09:37:43 AM
#642   Given its low market cap. and strong oncology Dr_Thorfin 10/03/16 11:53:16 AM
#641   I bought a position in here today based Bickema 10/03/16 10:57:59 AM
#640   Product just launched, not worth the fully potential Dr_Thorfin 09/30/16 01:46:59 PM
#639   Hey Dr Thorfin, im just doing some digging Bickema 09/30/16 01:36:48 PM
#638   Here is a list of upcoming catalysts Dr_Thorfin 09/30/16 04:54:46 AM
#637   Valeant And Progenics Announce The U.S. Commercial Launch Dr_Thorfin 09/06/16 09:00:49 PM
#636   4 trading days before oral relistor launch Dr_Thorfin 09/02/16 01:15:58 PM
#634   http://stockcharts.com/c-sc/sc?s=pgnx&p=D&yr=0&mn=16&dy=0&i=p32904265710&r= Dr_Thorfin 08/05/16 04:50:26 PM
#633   Valeant’s Relistor Said to Draw Interest of Potential Dr_Thorfin 08/05/16 04:07:19 PM
#632   Earnings call good morning to everybody joining us Dr_Thorfin 08/04/16 12:31:52 PM
#631   Progenics Pharmaceuticals (NASDAQ:PGNX) is another deeply undervalued biopharma Dr_Thorfin 08/04/16 10:53:50 AM
#630   On July 19, the Company Announced FDA Approval Dr_Thorfin 08/04/16 10:28:41 AM
#629   Sadly enough we have valeant as partner If it Dr_Thorfin 07/29/16 07:44:01 AM
#628   50 mil payoff and we bleed out? jonnyvs 07/28/16 03:28:11 PM
#627   Short interest is up, imo VRX is going Sugarplum 07/28/16 10:34:33 AM
#626   Basing beautifully around or above .06 IMO . jonnyvs 07/27/16 01:18:03 PM
#625   50 mil means ramping up R&D without any Dr_Thorfin 07/26/16 09:10:52 AM
#624   Booooom! 50 million! jonnyvs 07/26/16 08:49:06 AM
#623   Should see nice gains this week IMO jonnyvs 07/25/16 09:51:07 AM
#622   PGNX bullish 6.11 stocktrademan 07/22/16 12:12:40 PM
#621   Damn,Over 200k shares And i thought i was a Dr_Thorfin 07/21/16 03:50:46 PM
#620   Huuuuuge buy jonnyvs 07/21/16 02:59:28 PM
PostSubject